PortfoliosLab logoPortfoliosLab logo
LYSDY vs. AYTU
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LYSDY vs. AYTU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lynas Rare Earths Ltd ADR (LYSDY) and Aytu BioPharma, Inc. (AYTU). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LYSDY achieves a 54.78% return, which is significantly higher than AYTU's -19.04% return.


LYSDY

1D
1.43%
1M
-4.23%
YTD
54.78%
6M
56.67%
1Y
104.80%
3Y*
36.62%
5Y*
25.57%
10Y*
75.49%

AYTU

1D
1.20%
1M
0.24%
YTD
-19.04%
6M
-18.09%
1Y
6.85%
3Y*
4.97%
5Y*
-53.28%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

LYSDY vs. AYTU - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LYSDY
Lynas Rare Earths Ltd ADR
54.78%109.37%-18.22%-8.17%-29.21%144.41%79.88%50.87%489.58%146.75%
AYTU
Aytu BioPharma, Inc.
-19.04%52.94%-40.14%-24.87%-86.00%-77.42%-38.35%22.41%-98.22%-89.38%

Correlation

The correlation between LYSDY and AYTU is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.09

Correlation (3Y)
Calculated over the trailing 3-year period

0.09

Correlation (5Y)
Calculated over the trailing 5-year period

0.12

Correlation (All Time)
Calculated using the full available price history since Feb 1, 2017

0.08

Fundamentals

Market Cap

LYSDY:

$12.58B

AYTU:

$22.13M

EPS

LYSDY:

A$0.14

AYTU:

-$2.91

PS Ratio

LYSDY:

14.61

AYTU:

0.44

PB Ratio

LYSDY:

5.29

AYTU:

0.63

Total Revenue (TTM)

LYSDY:

A$1.19B

AYTU:

$56.60M

Gross Profit (TTM)

LYSDY:

A$301.27M

AYTU:

$36.14M

EBITDA (TTM)

LYSDY:

A$236.57M

AYTU:

-$27.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LYSDY vs. AYTU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LYSDY
LYSDY Risk / Return Rank: 7979
Overall Rank
LYSDY Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
LYSDY Sortino Ratio Rank: 7979
Sortino Ratio Rank
LYSDY Omega Ratio Rank: 7777
Omega Ratio Rank
LYSDY Calmar Ratio Rank: 7878
Calmar Ratio Rank
LYSDY Martin Ratio Rank: 7676
Martin Ratio Rank

AYTU
AYTU Risk / Return Rank: 4646
Overall Rank
AYTU Sharpe Ratio Rank: 4747
Sharpe Ratio Rank
AYTU Sortino Ratio Rank: 4545
Sortino Ratio Rank
AYTU Omega Ratio Rank: 4444
Omega Ratio Rank
AYTU Calmar Ratio Rank: 4747
Calmar Ratio Rank
AYTU Martin Ratio Rank: 4747
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LYSDY vs. AYTU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lynas Rare Earths Ltd ADR (LYSDY) and Aytu BioPharma, Inc. (AYTU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LYSDYAYTUDifference
Sharpe ratioReturn per unit of total volatility

+1.50

Sortino ratioReturn per unit of downside risk

+1.57

Omega ratioGain probability vs. loss probability

1.27

1.07

+0.20

Calmar ratioReturn relative to maximum drawdown

2.27

0.19

+2.08

Martin ratioReturn relative to average drawdown

4.71

0.45

+4.26

LYSDY vs. AYTU - Sharpe Ratio Comparison

The current LYSDY Sharpe Ratio is 1.63, which is higher than the AYTU Sharpe Ratio of 0.13. The chart below compares the historical Sharpe Ratios of LYSDY and AYTU, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

LYSDY vs. AYTU - Drawdown Comparison

The maximum LYSDY drawdown since its inception was -99.93%, roughly equal to the maximum AYTU drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for LYSDY and AYTU.


Loading charts...

Drawdown Indicators


LYSDYAYTUDifference

Max Drawdown

Largest peak-to-trough decline

-99.93%

-100.00%

+0.07%

Max Drawdown (1Y)

Largest decline over 1 year

-46.39%

-35.47%

-10.92%

Max Drawdown (3Y)

Largest decline over 3 years

-46.39%

-70.24%

+23.85%

Max Drawdown (5Y)

Largest decline over 5 years

-58.25%

-99.12%

+40.87%

Max Drawdown (10Y)

Largest decline over 10 years

-72.35%

Current Drawdown

Current decline from peak

-53.71%

-100.00%

+46.29%

Average Drawdown

Average peak-to-trough decline

-84.46%

-95.27%

+10.81%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.34%

15.43%

+6.91%

Volatility

LYSDY vs. AYTU - Volatility Comparison

Lynas Rare Earths Ltd ADR (LYSDY) and Aytu BioPharma, Inc. (AYTU) have volatilities of 13.49% and 13.25%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LYSDYAYTUDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.49%

13.25%

+0.24%

Volatility (6M)

Calculated over the trailing 6-month period

43.58%

34.09%

+9.49%

Volatility (1Y)

Calculated over the trailing 1-year period

64.72%

54.79%

+9.93%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

50.63%

85.68%

-35.05%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

278.59%

187.90%

+90.69%

Dividends

LYSDY vs. AYTU - Dividend Comparison

Neither LYSDY nor AYTU has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

LYSDY vs. AYTU - Financials Comparison

This section allows you to compare key financial metrics between Lynas Rare Earths Ltd ADR and Aytu BioPharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M600.00M202120222023202420252026
406.10M
12.41M
(LYSDY) Total Revenue
(AYTU) Total Revenue
Please note, different currencies. LYSDY values in AUD, AYTU values in USD

LYSDY vs. AYTU - Profitability Comparison

The chart below illustrates the profitability comparison between Lynas Rare Earths Ltd ADR and Aytu BioPharma, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%202120222023202420252026
28.2%
61.2%
Portfolio components
LYSDY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Lynas Rare Earths Ltd ADR reported a gross profit of 114.53M and revenue of 406.10M. Therefore, the gross margin over that period was 28.2%.

AYTU - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aytu BioPharma, Inc. reported a gross profit of 7.60M and revenue of 12.41M. Therefore, the gross margin over that period was 61.2%.

LYSDY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Lynas Rare Earths Ltd ADR reported an operating income of 79.26M and revenue of 406.10M, resulting in an operating margin of 19.5%.

AYTU - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aytu BioPharma, Inc. reported an operating income of -4.06M and revenue of 12.41M, resulting in an operating margin of -32.8%.

LYSDY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Lynas Rare Earths Ltd ADR reported a net income of 78.74M and revenue of 406.10M, resulting in a net margin of 19.4%.

AYTU - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aytu BioPharma, Inc. reported a net income of -5.62M and revenue of 12.41M, resulting in a net margin of -45.3%.


Frequently Asked Questions


LYSDY and AYTU have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LYSDY has higher volatility (13.49%) compared to AYTU (13.25%). In terms of maximum drawdown, LYSDY dropped -99.93% vs AYTU's -100.00%.

LYSDY currently has the higher Sharpe Ratio (1.63 vs 0.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LYSDY and AYTU

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer